Streetbeat News

Products Services

BRDS

Bird Global, Inc. (NYSE:BRDS) has been granted a three-year permit extension to expand its electric scooter operations in Rome, Italy. The permit allows Bird to double its fleet size to approximately 4,500 scooters and integrate with the city's public transportation infrastructure.

Portfolio Pulse from Happy Mohamed

May 26, 2023 | 1:09 pm

OGI

Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI) has entered into an agreement with Phylos Bioscience Inc. to initiate a technical and commercial relationship in Canada. The partnership aims to support Organigram's cultivation efforts with patent-pending technologies and genetics. Organigram plans to export THCV products to select legal international markets in the future.

Portfolio Pulse from Vuk Zdinjak

May 26, 2023 | 1:06 pm

STIM

Neuronetics announces increased access to its NeuroStar Advanced Therapy for Mental Health through a healthcare policy update from BlueCross BlueShield (BCBS) of Michigan. The policy change expands eligibility for depression patients to receive transcranial magnetic stimulation (TMS) by reducing the number of antidepressant medication attempts required.

Portfolio Pulse from Happy Mohamed

May 26, 2023 | 1:01 pm

ZNTL

Zentalis Pharmaceuticals announced positive Phase 1b trial data for azenosertib in combination with chemotherapy in patients with platinum-resistant ovarian cancer. The company plans to initiate a Phase 3 study in Q1 2024.

Portfolio Pulse from Vandana Singh

May 26, 2023 | 12:55 pm

EFTR

ONFO

QH

eFFECTOR Therapeutics reports positive data from Phase 2 expansion cohorts for Zotatifin in ER+ metastatic breast cancer patients. Onfolio completes development of generative AI search tool. Quhuo's homestay sector achieves RMB12 million in sales during Labor Day holiday.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 12:54 pm

MRK

PDSB

PDS Biotechnology announced positive interim data from the VERSATILE-002 Phase 2 trial of PDS0101 in combination with Merck's Keytruda, in patients with HPV16-positive head and neck cancer. The 12-month overall survival rate was 87.1%, and median progression-free survival was 10.4 months. PDSB shares are up 26.96% in premarket trading.

Portfolio Pulse from Vandana Singh

May 26, 2023 | 12:48 pm

ONFO

Onfolio announced the completion of a generative AI search tool development, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 12:44 pm

EFTR

EFFECTOR Therapeutics reported positive data updates from the Phase 2 expansion cohorts evaluating zotatifin in patients with ER+ metastatic breast cancer at the ASCO 2023 Annual Meeting, leading to higher trading of its shares.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 12:44 pm

AMZN

GOOGL

NFLX

TSLA

Amazon Prime Video mocks Netflix's password crackdown with a meme, while Tesla faces safety concerns due to leaked data revealing thousands of complaints about self-acceleration and braking issues. Elon Musk's Neuralink receives FDA approval for human trials, and YouTube discontinues its Stories feature.

Portfolio Pulse from Vandana Singh

May 26, 2023 | 12:42 pm

CLPS

CLPS Incorporation announced that its majority-owned subsidiary, JAJI, is developing a new smart cockpit product aimed at improving safety for intelligent vehicles.

Portfolio Pulse from Benzinga Newsdesk

May 26, 2023 | 12:34 pm